ADAG - Adagene Inc

-

$undefined

N/A

(N/A)

Adagene Inc NASDAQ:ADAG Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

Location: 4f, Building C14, No. 218,, Xinghu Street, Suzhou Industrial Park, Jiangsu, 215123, China (Mainland) | Website: www.adagene.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

40.77M

Cash

95.67M

Avg Qtr Burn

-7.10M

Short % of Float

0.06%

Insider Ownership

10.66%

Institutional Own.

25.20%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.